7Baggers
 regulus therapeutics inc (rgls) institutional confidence  TradingKey Thu, 18 Jun 2026 21:01:23 GMT
 regulus therapeutics (rgls) status update summary  Quartr Sat, 25 Apr 2026 16:38:37 GMT
 rgls stock news today | earnings, events & price alerts  Intellectia AI Sat, 28 Feb 2026 06:17:20 GMT
 novartis ceo discusses future of bolt-on acquisitions plans  Global Banking & Finance Review® Tue, 13 Jan 2026 08:00:00 GMT
 novartis eyes more bolt-on acquisitions, ceo says  WKZO Mon, 12 Jan 2026 08:00:00 GMT
 published on: 2026-01-08 18:34:03  ulpravda.ru Thu, 08 Jan 2026 14:34:03 GMT
 published on: 2025-12-19 16:00:37  DonanımHaber Fri, 19 Dec 2025 13:00:37 GMT
 novartis strikes deal with uk biotech for up to $1.7 billion  SWI swissinfo.ch Tue, 09 Dec 2025 09:48:43 GMT
 Novartis strikes deal with UK biotech for up to US$1.7 billion  The Business Times Tue, 09 Dec 2025 08:00:00 GMT

Regulus Therapeutics Inc
(NASDAQ:RGLS) 

RGLS stock logo

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the trea...

Founded: 2007
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends